Johnson & Johnson (JNJ) - Pharmaceutical Revenue (DISCONTINUED) (I:JJJNJPR)
52.56B USD for 2023
Level Chart
Basic Info
Johnson & Johnson (JNJ) - Pharmaceutical Revenue is at a current level of 52.56B, up from 45.57B one year ago. This is a change of 15.34% from one year ago. |
Pharmaceutical Revenue refers to the total revenue generated by Johnson & Johnson from its pharmaceutical segment. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 52.56B |
Latest Period | 2023 |
Last Updated | Jan 12 2024, 16:52 EST |
Average Growth Rate | 7.70% |
Value from 1 Year Ago | 45.57B |
Change from 1 Year Ago | 15.34% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |
Historical Data
Date | Value |
---|---|
January 01, 2023 | 52.56B |
January 02, 2022 | 51.68B |
January 03, 2021 | 45.57B |
December 29, 2019 | 42.20B |
December 30, 2018 | 40.73B |
December 31, 2017 | 36.26B |
Date | Value |
---|---|
January 01, 2017 | 33.46B |
January 03, 2016 | 31.43B |
December 28, 2014 | 32.31B |
December 29, 2013 | 28.12B |
December 30, 2012 | 25.35B |
News
Headline
Wire
Time (ET)
MT Newswires
12/18 04:38
PR Newswire
12/17 03:24
PR Newswire
12/10 08:00
PR Newswire
12/09 16:15
Accesswire
12/05 10:30
Globe Newswire
12/04 08:07
Basic Info
Johnson & Johnson (JNJ) - Pharmaceutical Revenue is at a current level of 52.56B, up from 45.57B one year ago. This is a change of 15.34% from one year ago. |
Pharmaceutical Revenue refers to the total revenue generated by Johnson & Johnson from its pharmaceutical segment. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 52.56B |
Latest Period | 2023 |
Last Updated | Jan 12 2024, 16:52 EST |
Average Growth Rate | 7.70% |
Value from 1 Year Ago | 45.57B |
Change from 1 Year Ago | 15.34% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |